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Signaling via the conserved WNT/β-CATENIN pathway controls diverse 
developmental processes. To explore its potential role in the ovary, we investigated the 
expression of WNTs, frizzled (FZD) receptors, and other pathway components in 
human cumulus cells obtained from oocytes collected for in vitro fertilization. Proteins 
were detected in cultured cells using immunofluorescence microscopy. Protein-protein 30 
interactions were analyzed by means of immunoprecipitation. WNT2, FZD2, FZD3, 
and FZD9 were identified but WNT1, WNT4 and FZD4 were not detected. WNT2 is 
co-expressed with FZD2, FZD3, and FZD9. Co-immunoprecipitation using WNT2 
antibody demonstrated that WNT2 interacts with both FZD3 and FZD9, but only 
FZD9 antibody precipitated WNT2. We also identified DVL (disheveled), AXIN, 35 
GSK-3β (glycogen synthase kinase-3β), and β-CATENIN. β-CATENIN is 
concentrated in the plasma membranes. DVL co-localizes with FZD9 and AXIN in the 
membranes, but GSK-3β has little colocalization with AXIN and β-CATENIN. 
Interestingly, β-CATENIN is highly co-localized with FZD9 and AXIN. CDH1 
(E-cadherin) was also detected in the plasma membranes and cytoplasm, co-localized 40 
with β-CATENIN, and CDH1 antibody precipitated β-CATENIN. The results suggest 
that WNT2 could act through its receptor FZD9 to regulate the β-CATENIN pathway 
in cumulus cells, recruiting β-CATENIN into plasma membranes and promoting the 
formation of adherens junctions involving CDH1. 
Keywords: ovarian follicle, paracrine signaling, folliculogenesis, gene expression, 45 
signal transduction, assisted reproduction 
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Introduction 
WNT genes encode a large family of secreted, cysteine-rich glycoproteins that have 
been implicated in a variety of cellular processes, such as cell fate specification, cell 
proliferation, differentiation, survival and apoptosis, polarity, and migration (Wodarz 50 
and Nusse, 1998; Hoppler and Kavanagh, 2007). Dysregulation of WNT signaling has 
been found to cause developmental defects and tumorigenesis (Logan and Nusse, 
2004). To date, 19 WNT members have been identified in human. Frizzled (FZD) 
receptors are a family of seven-transmembrane proteins, 10 of which are encoded in 
the human genome. The N-terminal extracellular cysteine-rich domain (CRD) has 55 
been identified as the WNT-binding domain (Dann et al., 2001). The WNT-FZD 
relationship is well characterized in Drosophila, however, the specificity of WNT-FZD 
interactions remains largely unresolved in vertebrates because of the large number of 
WNT and FZD genes and the numerous possibilities for WNT-FZD interactions and 
functional redundancies (Rulifson et al., 2000; Hsieh et al., 1999).  60 
 The canonical WNT pathway is well understood for its ability to regulate cell-cell 
adhesion and cell cycle control, and β-CATENIN is the central and essential 
component in this pathway (Mulholland et al., 2005). In the absence of WNT 
activation, β-CATENIN is tightly regulated through phosphorylation at specific 
N-terminal residues by a destruction complex that includes casein kinase-1α (CK1α), 65 
glycogen synthase kinase-3 (GSK3), along with tumor suppressors adenomatous 
polyposis coli (APC) and AXIN. Phosphorylated β-CATENIN is targeted for rapid 
ubiquitinylation and degradation in the 26S proteasome (Gordon and Nusse, 2006; 
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Habas and Dawid, 2005). Disheveled (DVL) is, at present, the only known key 
intermediate connecting FZD and the downstream β-CATENIN pathway, and may 70 
bind directly to the FZD C-terminal region via a PDZ domain (Wong et al., 2003). 
Following WNT binding to the receptor complex consisting of FZD and lipoprotein 
receptor-related protein 5 and 6 (LRP5/6), the activation of the phosphoprotein DVL 
recruits AXIN and the destruction complex to the plasma membrane. AXIN is then 
degraded by proteasomes, which decreases β-CATENIN degradation. The activation 75 
of DVL also leads to the destabilization of the destruction complex and inhibition of 
GSK3, which further reduces the phosphorylation and degradation of β-CATENIN 
(Gordon and Nusse, 2006; Moon et al., 2004). As a result, hypophosphorylated 
β-CATENIN accumulates in the cytoplasm and is translocated to the nucleus where it 
interacts with the T-cell factor and lymphoid enhancer-binding factor (TCF/LEF) 80 
family of transcription factors to activate the transcription of target genes (Gordon and 
Nusse, 2006). In addition to its function in the WNT pathway, β-CATENIN also 
functions as a key component of the cadherin complex, which controls cell-cell 
adhesion and influences cell migration (Bienz, 2005; Nelson and Nusse, 2004). 
    Ovarian folliculogenesis requires complex regulatory mechanisms involving both 85 
endocrine and intra-ovarian signaling pathways. Recently, WNT signaling has been 
implicated in ovarian development, oogenesis, and early development. Wnt4 deficient 
mice exhibit sex reversal and a paucity of oocytes in the newborn ovary, while mice 
null for Fzd4 are infertile and exhibit impaired function of the corpus luteum (Vionio et 
al., 1999; Hsieh et al., 2005). Multiple Wnt transcripts are localized in the different 90 
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compartments of the mouse ovary: Wnt2 and Fzd1 are expressed in the granulosa cells 
while Wnt4 and Fzd4 are expressed in the corpus luteum (Ricken et al., 2002; Hsieh et 
al., 2002). It has been reported that misregulation of WNT/β-CATENIN signaling in 
granulosa cells can contribute to granulosa cell tumor development (Boerboom et al., 
2005).  95 
 The preovulatory oocyte is surrounded by several cell layers, known as the 
cumulus granulosa cells, which are metabolically coupled with each other and the 
oocyte through intercellular membrane channels (gap junctions) that facilitate 
exchange of small signaling molecules between the cells (Laird, 2006). The cumulus 
cells exhibit hormone responsiveness, a gene expression profile, and intercellular 100 
signaling distinct from those of the mural (outer) granulosa cell layers, which 
contribute to the oocyte through the final stage of its development (Russell and Robker, 
2007). However, very little is known about the expression or function of the 
WNT/β-CATENIN signaling pathway in the cumulus cells. This study was undertaken 
to explore the expression of WNT/β-CATENIN signaling proteins, the interaction of 105 
WNTs and FZD receptors, and the possible function of β-CATENIN in human 
cumulus cells. 
 
Materials and Methods 
Cumulus cell culture 110 
The acquisition and use of human cumulus cells was approved by the Health Sciences 
Research Ethics Board of the University of Western Ontario and all patients gave 
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informed consent. Cumulus granulosa cells were collected from oocytes being 
prepared for intracytoplasmic sperm injection (ICSI) as previously described (Wang et 
al., 2008). The cells were washed twice with culture medium consisting of 115 
DMEM/F12 (1:1) supplemented with 10% fetal bovine serum (FBS), 100 units/mL 
penicillin and 100 µg/mL streptomycin. The cells were grown on glass coverslips 
treated with 0.358 mg/mL collagen (BD Biosciences, Mississauga, ON, Canada) and 
cultured at 37°C, 5% CO2 in air for 24 hours. Cumulus cells from individual follicles 
were cultured separately. All products for this study were purchased from Invitrogen 120 
Canada Inc. (Burlington, ON) unless specifically mentioned.  
 
Immunofluorescence microscopy 
Information for all antibodies used in this study is listed in Table 1. As a positive 
control for each antibody, we also used it to stain mouse ovaries by 125 
immunohistochemistry. Cells grown on glass coverslips were fixed with pre-chilled 
methanol/acetone (4:1) at 4°C for 20 min and then rinsed with phosphate-buffered 
saline (PBS) to prepare them for immunostaining. Briefly, the cells were blocked with 
washing buffer containing 3% w/v bovine serum albumin (BSA) for 1 h, 
immunolabeled with primary antibody for 1 h, washed with PBS, and immunolabeled 130 
with appropriate secondary antibody for 1 h in the dark. For double-immunolabeling, 
cells were treated with the first primary antibody for 1 h and then with Alexa Fluor 
594-conjugated secondary antibody for 1 h, followed by treatment with the second 
primary antibody for 1 h and finally by an Alexa Fluor 488-conjugated secondary 
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antibody. Several washes were interposed between the different antibody incubations. 135 
Cells were washed in PBS and the nuclei stained with 0.1% Hoechst for 10 min 
followed by washes with PBS and double distilled H2O. The coverslips were mounted 
on slides with Airvol (Air Products & Chemicals, Inc., Allentown, PA, USA) before 
storage at 4°C. At least 50 patients contributed cumulus cells for this study, with at 
least 5 coverslips from each patient being analyzed by immunostaining with each 140 
antibody. The cells were imaged using a Zeiss (Thornwood, NY) LSM 510 META 
confocal microscope. Fluorescent signals were captured after excitation with 488, 543, 
or 730 nm laser lines. Digital images were prepared using Zeiss LSM and Adobe 
Photoshop 7.0 software. 
 145 
Co-immunoprecipitation 
Cumulus cells from all follicles of one or two patients collected on the same day were 
pooled for these analyses. Cumulus cells were lysed in immunoprecipitation (IP) 
buffer [125 mM NaCl, 20 mM Tris-Cl (pH 7.5), 1% Triton-X-100, 2 mM EDTA, 1 
mM Na3VO4, 1 mM NaF, and 1X protease inhibitor cocktail (Roche, Mannheim, 150 
Germany)]. Five-hundred µg total proteins were incubated with 3-5 µg of antibody 
against WNT2, FZD2, FZD3, FZD9 or CDH1 in 1.0 ml IP buffer on a rocker at 4°C 
overnight. The antibodies were precipitated with 50 µl of Dynabeads® Protein G for 2 
hours on a rocker at 4°C. The beads were washed twice with washing buffer (25 mM 
citric acid, 50 mM Na2HPO4, pH 5.0) and then eluted with 0.1 M citrate (pH 2-3). Fifty 155 
µg total protein before immunoprecipitation was set as the input sample, while the 
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sample without antibody incubation was considered as negative control. 
 
Immunoblotting 
All samples were boiled for 5 minutes and loaded on 12% SDS-PAGE gels. The 160 
proteins were transferred to nitrocellulose membrane (Amersham Pharmacia Biotech, 
Little Chalfout, Buckinghamshire, England). The membrane was blocked with 5% 
nonfat milk (w/v) in Tris-buffered saline Tween-20 (TBST) for 1 h, and subsequently 
probed with specific primary antibody other than the immunoprecipitating antibody 
overnight at 4°C followed by incubation with infrared fluorescent-labeled secondary 165 
antibody (Alexa-680 anti-rabbit, anti-goat or anti-mouse). Antibody binding was 
detected by use of the Odyssey infrared-imaging system (LI-COR Biosciences, 
Lincoln, NE). The membrane was stripped and re-probed with the same antibody used 
for immunoprecipitation, then incubated with the corresponding infrared 
fluorescent-labeled secondary antibody. The immunoblots were processed using 170 
LI-COR. Two washes with TBST were inserted between the antibody treatment steps.  
 
Results 
Detection of WNTs and FZDs in human cumulus cells 
To begin to explore WNT signaling in human cumulus cells, we looked for the 175 
expression of WNT1, WNT2, and WNT4. The results showed that WNT2 is expressed 
in cumulus cells, but WNT1 and WNT4 were not detected (Fig. 1A). The same WNT1 
antibody revealed strong immunoreactivity in oocytes and corpora lutea of mouse 
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ovaries but the WNT4 antibody did not reveal any distinct immunoreactivity (H.-X. 
Wang and G.M. Kidder, manuscript in preparation). It has been reported that FZD2, 180 
FZD3, FZD4 and FZD9 are potential receptors for WNT2 in Drosophila or 
mammalian cells (Wu and Nusse, 2002; Klein et al., 2008; Karasawa et al., 2002). In 
our study, FZD2, FZD3, and FZD9 but not FZD4 were detected (Fig. 1B); again, the 
FZD4 antibody did reveal expression of this protein in mouse oocytes and corpora 
lutea (H.-X. Wang and G.M. Kidder, manuscript in preparation). FZD2 is localized 185 
mainly in the cytoplasm (see also Fig. 2A showing colocalization with cytoplasmic 
WNT2), whereas FZD3 and FZD9 are localized in the cytoplasm and membranes.  
 
Interaction of WNT2 and its possible receptors 
We used double-label immunofluorescence to explore the co-localization of WNT2 190 
and FZDs in human cumulus cells. We found that WNT2 is co-expressed with each of 
FZD2, FZD3, and FZD9 (Fig. 2). WNT2 co-localizes with FZD2 in the cytoplasm (Fig. 
2A) and with FZD3 and FZD9 in both the membranes and cytoplasm (Fig. 2B and C). 
The possibility of direct interaction of WNT2 with the three receptors was then tested 
by co-immunoprecipitation experiments. When cell lysates were immunoprecipitated 195 
with antibody directed against WNT2, FZD3 and FZD9 were also found in the pellet, 
but FZD2 was not (Fig. 3A, B, C). Conversely, although WNT2 was precipitated by 
FZD9 antibody, FZD2 and FZD3 antibodies were ineffective (Fig. 3D). No protein 
bands were evident in cell lysates not treated with immunoprecipitating antibody 
(negative controls in Fig. 3A-D).  200 
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Expression of WNT2/β-CATENIN signaling proteins in human cumulus cells 
As reported previously, FZD9 is activated by WNT2 and functions through the 
WNT/β-CATENIN pathway (Karasawa et al., 2002). DVL, AXIN, GSK-3β, and 
β-CATENIN are four important molecules in this pathway (Gordon and Nusse, 2006). 205 
All four proteins were detected in human cumulus cells by immunofluorescence (Fig. 
4). The pattern of immunostaining for DVL, AXIN, and β-CATENIN indicated their 
localization in both the cell periphery and the perinuclear cytoplasm, whereas that for 
GSK-3β was clearly cytoplasmic. Co-immunolabeling experiments demonstrated that 
DVL colocalizes with FZD9 and AXIN in the membranes (Fig. 5A and B) while 210 
GSK-3β is localized mostly in the cytoplasm, with little colocalization with AXIN or 
β-CATENIN (Fig. 5C and D). Interestingly, FZD9 is highly co-localized with 
β-CATENIN in the cell membranes (Fig. 5E).  
 
Localization of β-CATENIN in cumulus cells 215 
As recently reported, activation of the WNT pathway recruits dephosphorylated 
β-CATENIN into the plasma membrane where it colocalizes with two members of the 
destruction complex, APC and AXIN (Hendriksen et al., 2008). Our results indicate 
that AXIN is highly localized with β-CATENIN in the cytoplasm of cumulus cells (Fig. 
6A). As a component of adherens junctions, β-CATENIN promotes cell adhesion by 220 
binding to the intracellular domain of the transmembrane protein, epithelial cadherin 
(CDH1) (Bienz, 2005). CDH1 was also detected in human cumulus cells, with some 
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junction-like plaques being found between the cells (arrows in Fig. 6B). 
Co-immunoprecipitation confirmed that β-CATENIN interacts with CDH1 in human 
cumulus cells (Fig. 6C). Co-immunolabeling further confirmed that CDH1 225 
co-localizes with β-CATENIN to a limited extent in the membranes (Fig. 6D). 
 
Discussion 
WNTs comprise a large family of secreted glycoproteins that are responsible for key 
developmental processes including cell proliferation, cell polarity, and cell fate 230 
determination. Conventional WNT signaling causes β-CATENIN accumulation in a 
complex with the transcription factor TCF/LEF that regulates target gene expression 
(Wodarz and Nusse, 1998; Hoppler and Kavanagh, 2007). Dysregulation of WNT 
signaling is linked to a range of diseases, most notably cancer (Logan and Nusse, 
2004). A few reports have indicated that WNT signaling plays a key role in 235 
development of the ovary, and WNT pathway components are normally expressed in 
ovarian granulosa cells (Vionio et al., 1999; Hsieh et al., 2005; Ricken et al., 2002; 
Hsieh et al., 2002). Aberrant WNT signaling leads to granulosa cell tumorigenesis 
(Boerboom et al., 2005). These findings suggest that WNT signaling is important for 
follicular development. However, we know little about WNT signaling in human 240 
ovarian follicles and its roles in folliculogenesis. It was thus important to explore the 
expression of WNT signaling components in human cumulus cells.  
    Previous experiments revealed that WNT2 mRNA is concentrated in the cumulus 
granulosa cells of rat ovaries and that WNT4 mRNA is expressed in small growing 
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follicles and corpora lutea of mouse ovaries (Ricken et al., 2002; Hsieh et al., 2002). In 245 
the present study, we only detected the expression of WNT2 in human cumulus cells; 
WNT1 and WNT4 were not detected. Neither of the two different WNT4 antibodies 
we used, both of which have been successfully used by others, revealed the presence of 
this protein in mouse ovaries either. We are unaware of any report confirming 
expression of WNT4 in adult ovaries at the protein level. Therefore, we think it 250 
unlikely that WNT4 is present in our human cumulus cell samples, although some 
uncertainty still exists. Since WNT4 might function to regulate earlier stages of follicle 
growth, and cumulus cells from ISCI patients are mostly retrieved from large mature 
follicles, the absence of WNT4 is perhaps not surprising.  
 To verify that the WNT2 signaling pathway is intact in cumulus cells, we looked 255 
for the presence of possible receptors. It has been demonstrated that FZD2 and FZD3 
interact with WNT2 in Drosophila (Wu and Nusse, 2002), that FZD4 is the receptor 
for WNT2 in rat hepatic sinusoidal endothelial cells and human colon-derived cells 
(Klein et al., 2008; Planutis et al., 2007), and that FZD9 is activated by WNT2 in 
transfected 293 cells (Karasawa et al., 2002). FZD4 was only found in rat but not 260 
mouse granulosa cells (Ricken et al., 2002; Hsieh et al., 2002). Here we confirmed the 
expression of FZD2, FZD3, and FZD9 but failed to find FZD4 in human cumulus cells. 
FZD4 plays an essential role in the mouse ovary since Fzd4 null mice are infertile and 
exhibit impaired corpus luteum formation and function (Hsieh et al., 2005); if FZD4 is 
similarly involved in human folliculogenesis, its expression must be restricted to the 265 
mural granulosa cells or activated only after ovulation. Co-expression and 
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co-immunoprecipitation experiments demonstrated that WNT2 interacts with FZD3 
and FZD9 in human cumulus cells, but since only FZD9 antibody could 
immunoprecipitate WNT2, it must be considered the most likely receptor candidate. 
Although the WNT2 antibody had weak ability to precipitate FZD3, two different 270 
FZD3 antibodies failed to precipitate WNT2. One possible explanation for these 
results is that WNT2 associates only weakly or infrequently with FZD3 in cumulus 
cells. Further study is needed to determine whether FZD3 is another potential receptor 
for WNT2 in human cumulus cells. 
   It has been demonstrated that FZD and DVL are essential in both the canonical and 275 
noncanonical WNT pathways. In transfected 293 cells, FZD9 is activated by WNT2 
and functions through the β-CATENIN pathway (Karasawa et al., 2002). β- CATENIN 
is a key effector of WNT/β-CATENIN signaling and is regulated by the cytoplasmic 
destruction complex formed by AXIN, GSK-3β, and APC. In this study, we detected 
the expression of DVL, AXIN, GSK-3β, and β-CATENIN in human cumulus cells. 280 
DVL is co-localized with FZD9 and AXIN in the plasma membranes, indicating that 
FZD9 can activate the cytoplasmic protein DVL and recruit it into the membrane, 
where it then interacts with AXIN. This interpretation is supported by the observations 
that overexpression of FZD9 induces the hyperphosphorylation and relocation of 
mouse DVL-1 from the cytoplasm to the cell membrane, and DVL-2 promotes the 285 
recruitment of AXIN to the plasma membrane during WNT signaling (Karasawa et al., 
2002; Schwarz-Romond et al., 2007). Once AXIN is recruited into the membrane, it is 
then degraded by proteasomes leading to inhibition of the activity of the destruction 
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complex. The activation of DVL also leads to inhibition of GSK-3β, which further 
contributes to β-CATENIN accumulation (Moon et al., 2004; Schwarz-Romond et al., 290 
2007). These results directly support our finding that GSK-3β is not co-localized with 
AXIN and β-CATENIN in human cumulus cells.  
    An interesting finding of our study is that β-CATENIN is mostly localized in the 
membrane of cumulus cells, and that FZD9 is highly co-localized with β-CATENIN in 
the plasma membrane. These data indicate that FZD9 will activate β-CATENIN and 295 
recruit it into the membrane. In line with this, Hendriksen et al. (2008) have recently 
shown that endogenous dephosphorylated β-CATENIN appears on the membrane 
upon WNT3A treatment. This translocation occurs independently of CDH1, and 
β-CATENIN is co-localized with phospho-LRP6, AXIN, and APC. We also found 
co-localization of AXIN and β-CATENIN in human cumulus cells. However, the 300 
mechanism and function of the recruitment of β-CATENIN into membranes remain 
unclear. Aside from its function in WNT signaling, β-CATENIN was initially 
discovered by virtue of its role in forming adherens junctions with CDH1 (Nelson and 
Nusse, 2004; Brembeck et al., 2006). The expression of CDH1/CATENIN complexes 
had been identified in the rat ovary, suggesting that this complex might play roles in 305 
follicle development and luteinization (Sundfeldt et al., 2000). In our study, CDH1 was 
detected in junction-like plaques between cumulus cells and CDH1 antibody 
precipitated β-CATENIN; furthermore, CDH1 co-localized with β-CATENIN in some 
cells. Thus, β-CATENIN in cumulus cells may play a role not only in WNT signaling, 
but also in forming adherens junctions with CDH1.  310 
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    In summary, our results are consistent with the possibility that WNT2 signals 
through its receptor FZD9 to regulate the β-CATENIN pathway in human cumulus 
cells, potentially recruiting β-CATENIN into the plasma membrane and promoting the 
formation of adherens junctions involving CDH1. Our recent work with cultured 
mouse granulosa cells (Wang and Kidder, in preparation) has revealed that WNT2 315 
stimulates proliferation, suggesting that it may also act as a mitogen to promote follicle 
growth. Thus, WNT2/β-CATENIN signaling might play an important role in human 
folliculogenesis.  
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Table I.  Details of antibodies used. 430 
Applicationa 
Name Company 
IF IB IP 
Goat anti-WNT1 Santa Cruz 1: 100   
Goat anti-WNT2 Santa Cruz 1: 100 1: 200 4.0 µg 
Goat anti-WNT4 R&D Systems 1: 100   
Rabbit anti-FZD2 Zymed 1:100 1:400 5.0 µg 
Rabbit anti-FZD3 Sigma 1:200 1: 1,000  
Goat anti-FZD3 US Biological  1: 500 3.0 µg 
Mouse anti-FZD3 Abnova Corporation  1: 1,000 3.0 µg 
Rabbit anti-FZD4 Abcam 1: 200   
Rabbit anti-FZD9 Abcam 1:200 1: 1,000  
Goat anti-FZD9 Santa Cruz 1:100 1: 300 4.0 µg 
Rabbit anti-FZD9 MBL International Corp. 1:100 1: 1,000 3.0 µg 
Goat anti-DVL Santa Cruz 1:100   
Rabbit anti-DVL Abcam 1: 100   
Goat anti-AXIN Santa Cruz 1:100   
Mouse anti-GSK-3β Santa Cruz 1: 200   
Rabbit anti-β-CATENIN Chemicon 1:500 1: 1,000  
Mouse anti-CDH1 Zymed 1:100 1: 500 5.0 µg 
Mouse anti-CDH1 Abcam 1: 200 1: 1,000  
Alexa Fluor 488 goat anti rabbit Molecular probes 1:500   
Alexa Fluor 488 goat anti mouse Molecular probes 1:500   
Alexa Fluor 488 rabbit anti goat Molecular probes 1:500   
Alexa Fluor 594 goat anti rabbit Molecular probes 1:300   
Alexa Fluor 594 goat anti mouse Molecular probes 1:300   
Alexa Fluor 680 goat anti rabbit Molecular probes  1: 10,000  
Alexa Fluor 680 donkey anti rabbit Molecular probes  1: 10,000  
Alexa Fluor 680 rabbit anti mouse Molecular probes  1: 10,000  
aIF, immunofluorescence; IB, immunoblotting; IP, immunoprecipitation. 
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Figure legends 
Figure 1.  Expression of WNTs and FZDs in human cumulus cells. (A) Strong 435 
immunostaining was observed for WNT2, but WNT1 and WNT4 were not detected. (B) 
Potential WNT2 receptors FZD2, FZD3, and FZD9 were detected but FZD4 was not. 
Hoechst dye was used for nucleus staining. Scale bars = 50 µm.  
 
Figure 2.  Co-immunolabeling for WNT2 and its potential receptors FZD2, FZD3, 440 
and FZD9 in human cumulus cells. WNT2 colocalizes with FZD2 (A), FZD3 (B), and 
FZD9 (C) in individual cells. Hoechst dye was used for nucleus staining. The same 
magnification was used for all micrographs; scale bar = 50 µm. 
 
Figure 3. Co-immunoprecipitation tests for interaction of WNT2 with its potential 445 
receptors. WNT2 antibody immunoprecipitated FZD3 (B) and FZD9 (C) but not FZD2 
(A). CoIP: co-immunoprecipitation; IP: immunoprecipitation; IB: immunoblotting. (D) 
WNT2 was immunoprecipitated with FZD9 antibody but not with FZD2 or FZD3 
antibody.  
 450 
Figure 4.  Localization of DVL, AXIN, GSK-3β, and β-CATENIN in human 
cumulus cells. Arrows indicate putative membrane staining. Hoechst dye was used for 
nucleus staining. The same magnification was used for all micrographs; scale bar = 50 
µm. 
 455 
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Figure 5.  Co-expression of WNT/β-CATENIN signaling proteins in human cumulus 
cells. (A, B) Colocalization of DVL with FZD9 (A) and AXIN (B). (C,D) 
Co-expression but limited colocalization of GSK-3β with AXIN (C) and β-CATENIN 
(D). (E) Extensive colocalization of FZD9 and β-CATENIN. Hoechst dye was used for 
nucleus staining. The same magnification was used for all micrographs; scale bar = 50 460 
µm. 
 
Figure 6.   Localization of β-CATENIN in human cumulus cells. (A) Co-localization 
of AXIN and β-CATENIN. (B) Expression of CDH1 (arrows indicate junction-like 
plaques). (C) Immunoprecipitation of β-CATENIN with CDH1 antibody. (D) Limited 465 
colocalization of CDH1 and β-CATENIN. Hoechst dye was used for nucleus staining. 
The same magnification was used for all micrographs; scale bar = 50 µm. 
  
24
Figures 
Figure 1 
 470 
  
25
Figure 2  
 
  
26
Figure 3 
 
 475 
  
27
Figure 4  
 
 
  
28
Figure 5  
 480 
  
29
Figure 6 
 
 
